These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34155352)

  • 1. Media and strain studies for the scaled production of cis-enone resorcylic acid lactones as feedstocks for semisynthesis.
    Al Subeh ZY; Raja HA; Obike JC; Pearce CJ; Croatt MP; Oberlies NH
    J Antibiot (Tokyo); 2021 Aug; 74(8):496-507. PubMed ID: 34155352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cis-enone resorcylic acid lactones (RALs) as irreversible protein kinase inhibitors.
    Wei L; Wu J; Li G; Shi N
    Curr Pharm Des; 2012; 18(9):1186-98. PubMed ID: 22316158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides.
    Schirmer A; Kennedy J; Murli S; Reid R; Santi DV
    Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4234-9. PubMed ID: 16537514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent syntheses of resorcylic acid lactones: L-783277, LL-Z1640-2, and hypothemycin.
    Dakas PY; Jogireddy R; Valot G; Barluenga S; Winssinger N
    Chemistry; 2009 Nov; 15(43):11490-7. PubMed ID: 19821460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta resorcylic acid lactones (RALs) from fungi: chemistry, biology, and biosynthesis.
    Bang S; Shim SH
    Arch Pharm Res; 2020 Nov; 43(11):1093-1113. PubMed ID: 33113097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resorcylic acid lactones with cytotoxic and NF-κB inhibitory activities and their structure-activity relationships.
    Ayers S; Graf TN; Adcock AF; Kroll DJ; Matthew S; Carcache de Blanco EJ; Shen Q; Swanson SM; Wani MC; Pearce CJ; Oberlies NH
    J Nat Prod; 2011 May; 74(5):1126-31. PubMed ID: 21513293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation, semisynthesis, covalent docking and transforming growth factor beta-activated kinase 1 (TAK1)-inhibitory activities of (5Z)-7-oxozeaenol analogues.
    Fakhouri L; El-Elimat T; Hurst DP; Reggio PH; Pearce CJ; Oberlies NH; Croatt MP
    Bioorg Med Chem; 2015 Nov; 23(21):6993-9. PubMed ID: 26481152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase.
    Ninomiya-Tsuji J; Kajino T; Ono K; Ohtomo T; Matsumoto M; Shiina M; Mihara M; Tsuchiya M; Matsumoto K
    J Biol Chem; 2003 May; 278(20):18485-90. PubMed ID: 12624112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural resorcylic acid lactones: A chemical biology approach for anticancer activity.
    Kuttikrishnan S; Prabhu KS; Al Sharie AH; Al Zu'bi YO; Alali FQ; Oberlies NH; Ahmad A; El-Elimat T; Uddin S
    Drug Discov Today; 2022 Feb; 27(2):547-557. PubMed ID: 34655796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-Oxozeaenol.
    Wu J; Powell F; Larsen NA; Lai Z; Byth KF; Read J; Gu RF; Roth M; Toader D; Saeh JC; Chen H
    ACS Chem Biol; 2013 Mar; 8(3):643-50. PubMed ID: 23272696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (5Z)-7-Oxozeaenol: A novel and potent resorcylic acid lactone kinase inhibitor with a cis-enone Michael acceptor.
    Ellestad GA
    Chirality; 2019 Feb; 31(2):110-117. PubMed ID: 30565749
    [No Abstract]   [Full Text] [Related]  

  • 12. Conformational analyses and MO studies of f152A1 and its analogues as potent protein kinase inhibitors.
    Ikemori-Kawada M; Kawai T; Goto M; Wang YJ; Kawakami Y
    J Chem Inf Model; 2009 Dec; 49(12):2650-9. PubMed ID: 19995092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resorcylic acid lactone biosynthesis relies on a stereotolerant macrocyclizing thioesterase.
    Heberlig GW; Wirz M; Wang M; Boddy CN
    Org Lett; 2014 Nov; 16(22):5858-61. PubMed ID: 25372311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of endotoxin-induced TNF-alpha production in macrophages by 5Z-7-oxo-zeaenol and other fungal resorcylic acid lactones.
    Rawlins P; Mander T; Sadeghi R; Hill S; Gammon G; Foxwell B; Wrigley S; Moore M
    Int J Immunopharmacol; 1999 Dec; 21(12):799-814. PubMed ID: 10606001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resorcylic acid lactones as the protein kinase inhibitors , naturally occuring toxins.
    Patocka J; Soukup O; Kuca K
    Mini Rev Med Chem; 2013 Nov; 13(13):1873-8. PubMed ID: 24070207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resorcylic Acid Lactones from an
    Zhou J; Gao Y; Chang JL; Yu HY; Chen J; Zhou M; Meng XG; Ruan HL
    J Nat Prod; 2020 May; 83(5):1505-1514. PubMed ID: 32323537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to resorcylic acid lactones via phosphonate based intramolecular olefination.
    Napolitano C; McArdle P; Murphy PV
    J Org Chem; 2010 Nov; 75(21):7404-7. PubMed ID: 20939525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemistry and biology of resorcylic acid lactones.
    Winssinger N; Barluenga S
    Chem Commun (Camb); 2007 Jan; (1):22-36. PubMed ID: 17279252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of FLT3 covalent inhibitors with a resorcylic acid core.
    Xu J; Ong EHQ; Hill J; Chen A; Chai CLL
    Bioorg Med Chem; 2014 Dec; 22(23):6625-6637. PubMed ID: 25456387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design of resorcylic acid lactone analogues as covalent MNK1/2 kinase inhibitors by tuning the reactivity of an enamide Michael acceptor.
    Xu J; Chen A; Joy J; Xavier VJ; Ong EH; Hill J; Chai CL
    ChemMedChem; 2013 Sep; 8(9):1483-94. PubMed ID: 23929665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.